Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.
Type One Energy has raised more than $160 million from investors to date. The new funding will help the company further refine its stellarator technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback